Press What’s news at AbelsonTaylor Group
Select category
Agency 100 Studio Session: AbelsonTaylor | The future of generative AI in pharma marketing
AT’s VP – Director of Engagement Strategy Sharlene Jenner discusses some of the opportunities and challenges generative AI will bring in the future of pharma marketing. Through this podcast, Sharlene discusses how marketers must bring their teams together to maximize the new technology, while also trying to gain a better understanding of privacy laws, and intellectual property protection.
Read more at MM+M Online.
Media Contact:
Recent Posts
Annual Report Healthcare Communications Agencies: Artificial Intelligence Brings Real Results
Leaders at AbelsonTaylor Group say the agency is harnessing AI-enabled messaging tools through a custom-built AI platform called Lexi. ‘Lexi...
In the News Read more Annual Report Healthcare Communications Agencies: Artificial Intelligence Brings Real ResultsMedAdNews Agency Profile 2025: AbelsonTaylor Group
MedAdNews profiles AbelsonTaylor Group in its annual Agency Issue, highlighting AT Group’s “significant market wins,” new AI tools and initiatives...
In the News Read more MedAdNews Agency Profile 2025: AbelsonTaylor GroupAs Bluesky continues to grow, opportunities abound for pharma brands
With over 30 million users, Bluesky Social is quickly gaining steam. Associate Director of Engagement Helen Hoye recently spoke to...
In the News Read more As Bluesky continues to grow, opportunities abound for pharma brandsConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.